In agreement with this, Yu et al. reported that inhaled corticosteroid treatment for three months significantly reduced blood ILC2 levels and that this was associated with a decrease in serum IL-13 levels and improvements in lung function and asthma control in patients with both moderate asthma and asthma with allergic rhinitis [37]. The gene discussed is IL13; the disease is asthma.